why choose us

Clinical Trials Search

Showing 9,960 of 132,366 result(s)
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia

Status: Completed

Condition: Chronic Lymphocytic Leukemia

Interventions: Given PO

Date: 2023-07-05

Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Status: Completed

Condition: Post Traumatic Stress Disorder

Interventions: Daridorexant will be administered 50 mg once daily at least 2 hours after the last meal and within 30 minutes of going to bed.

Date: 2023-07-05

The Fourth Left Atrial Appendage Occlusion Study

Status: Completed

Condition: Atrial Fibrillation

Interventions: Participants will undergo endovascular left atrial appendage occlusion with the WATCHMAN device

Date: 2023-07-05

Comparison of Sepsis Prediction Algorithms

Status: NOT_YET_RECRUITING

Condition: Sepsis

Interventions: The Epic Sepsis Model (ESM) version 1, a proprietary sepsis prediction model.

Date: 2023-07-05

The Impact of Online Educator Mircoskill Training and Parent Microskill Training on Student Sexual-Health Related Outcomes

Status: Completed

Condition: HIV;AIDS Prevention

Interventions: Online Educator Mircoskill Training and Parent Microskill Training

Date: 2023-07-05

GyroGlove Use in Essential Tremor Patients

Status: NOT_YET_RECRUITING

Condition: Essential Tremor

Interventions: The placebo device consists of the same hardware as GyroGlove: aesthetically it looks the same, weight same and produces the same noise as GyroGlove.<

Date: 2023-07-05

Virtual Rehabilitation in HCT

Status: Completed

Condition: Hematopoietic Cell Transplant

Interventions:

Participants will have two 30-minute sessions per week for 12 weeks.
The program will focus on aerobic exercises and stretching exercises.

Date: 2023-07-05

Erbium, Chromium: Yttrium, Scandium, Gallium, Garnet (Er,Cr:YSGG) Laser in Root Canal Disinfection

Status: Completed

Condition: Endodontic Disease

Interventions: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300?m tip (EdgePro #3) will be placed into the mid-root of the canal.
The tip will be

Date: 2023-07-05

Magnesium as an Adjuvant Agent for Postoperative Pain

Status: NOT_YET_RECRUITING

Condition: Pain, Postoperative

Interventions: Participants will receive IV Magnesium Sulfate intraoperatively.

Date: 2023-07-05

Department of Defense PTSD Adaptive Platform Trial Intervention A - Fluoxetine

Status: Completed

Condition: Post Traumatic Stress Disorder

Interventions: Fluoxetine will be administered at 10 to 60 mg daily.
The initial dose for all participants will be 10 mg daily for 1 week, then increased to 20

Date: 2023-07-05